RIP3 is thought to maintain adipose tissue homeostasis and dampen inflammation by inhibiting caspase-8-dependent apoptosis of adipocytes, associated with a prevention of glucose intolerance, in the choline deficient-HFD dietary model of obesity (14). Here, RIPK3 is linked to obesity disorder.